Sino-Agri Leading Biosciences Co.,Ltd (SHA:603970)
China flag China · Delayed Price · Currency is CNY
11.52
+0.38 (3.41%)
Sep 7, 2026, 1:15 PM CST

SHA:603970 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,31911,24110,59610,46011,6998,822
Revenue Growth
4.71%6.09%1.30%-10.59%32.61%32.84%
Cost of Revenue
10,63110,5169,8789,75810,9728,292
Gross Profit
687.89724.44718.27701.54726.8530.36
Selling, General & Admin
309.61326.63321.85320.13294.73248.88
Research & Development
59.6465.3366.7465.3645.7937.53
Other Operating Expenses
7.097.680.046.889.3810.58
Operating Expenses
428.22451.53406.51420.26352.43295.38
Operating Income
259.66272.91311.76281.28374.37234.99
Interest Expense
-22.97-22.97-22.44-16.6-26.76-33.84
Interest & Investment Income
5.546.8318.4539.6628.6566.55
Currency Exchange Gain (Loss)
-28.19-28.19-0.03-16.22-15.1913.87
Other Non Operating Income (Expenses)
-36.77-16.66-11.32.09-29.78-8.65
EBT Excluding Unusual Items
177.28211.91296.43290.21331.3272.92
Gain (Loss) on Sale of Investments
17.2620.181.2611.83-18.55-13.55
Gain (Loss) on Sale of Assets
-0.61-0.41-0.60.71-0.770.3
Asset Writedown
4.95-1.24--0.240.29-27.19
Other Unusual Items
8.978.975.0112.6213.427.76
Pretax Income
207.85239.42302.11315.13325.69240.24
Income Tax Expense
47.653.373.2367.5577.854.6
Earnings From Continuing Operations
160.25186.12228.87247.58247.89185.64
Minority Interest in Earnings
-5.77-13.59-25.5-22.74-37.57-15.33
Net Income
154.48172.53203.38224.84210.32170.31
Net Income to Common
154.48172.53203.38224.84210.32170.31
Net Income Growth
-17.60%-15.17%-9.55%6.91%23.49%28.59%
Shares Outstanding (Basic)
269269269269269269
Shares Outstanding (Diluted)
269269269269269269
Shares Change
-0.01%-0.01%0.01%-0.01%0.00%-0.01%
EPS (Basic)
0.570.640.760.840.780.63
EPS (Diluted)
0.570.640.760.840.780.63
EPS Growth
-17.59%-15.16%-9.55%6.92%23.48%28.60%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,279-79.68305.21-948.571,532321.43
Free Cash Flow Per Share
4.76-0.301.14-3.535.701.20
Dividend Per Share
0.3200.3200.4500.4500.3930.250
Dividend Growth
-28.89%-28.89%0%14.53%57.16%16.66%
Gross Margin
6.08%6.44%6.78%6.71%6.21%6.01%
Operating Margin
2.29%2.43%2.94%2.69%3.20%2.66%
Profit Margin
1.36%1.54%1.92%2.15%1.80%1.93%
Free Cash Flow Margin
11.30%-0.71%2.88%-9.07%13.10%3.64%
EBITDA
267.72282.25322.32292.15387.06245.14
EBITDA Margin
2.37%2.51%3.04%2.79%3.31%2.78%
D&A For EBITDA
8.069.3410.5610.8712.6810.15
EBIT
259.66272.91311.76281.28374.37234.99
EBIT Margin
2.29%2.43%2.94%2.69%3.20%2.66%
Effective Tax Rate
22.90%22.26%24.24%21.44%23.89%22.73%
Revenue as Reported
11,24111,24110,59610,46011,6998,822
Advertising Expenses
-70.2155.3648.0340.4425.83